Health industry publications

The landscape of health policy, technology, and operations demands that professionals stay on top of key trends in the healthcare payer and provider, life sciences and pharmaceutical industries. PricewaterhouseCoopers' health industry publications focus on trends as well as key insights and best practices.

	Proposals to policy: A national conversation on healthcare reform Susan Dentzer, editor-in-chief of Health Affairs and health correspondent of The NewsHour with Jim Lehrer, moderated a panel of healthcare experts, economists and lawmakers as they discussed President-elect Obama's health care reform proposals. This broadcast was recorded from the National Press Club, Washington, D.C. on November 20, 2008.
	Healthcare policy in an Obama administration: Delivering on the promise of universal coverage President-elect Barack Obama has pledged to implement multiple changes in our health care system with the goal to increase access and affordability of health care in the United States. This report recognizes the difficulty in developing such reforms in light of current market conditions, the implications reforms could have and provides five suggestions to make health care more affordable. To find out more about how the President-elect proposes to implement changes to the existing health care system and the possible impact of such reforms read, Healthcare policy in an Obama administration: Delivering on the promise of universal coverage.
	Research rewired: Merging care and research information to improve knowledge discovery Today's ad hoc methods of managing research information are beginning to strain under increasing demands for new drugs, more personalized medicine, better diagnostic tools, and post-market safety monitoring. This report investigates the benefits, barriers, and emerging approaches to creating an integrated information environment that will help to shape scientific diagnostic, drug, and device discovery in the future. See more
	Top Eight Health Industry Issues in 2008 Health organizations face a pivotal year in 2008 as they anticipate the wildcard outcome of the presidential election. Meanwhile, they must prepare for impending changes — pharmaceutical and life sciences companies are adapting to a new safety agenda from the FDA including the agency’s expanded authority over post-market drug safety. See more
	Pharma 2020: The vision: Which path will you take? The current pharmaceutical industry business model is both economically unsustainable and operationally incapable of acting quickly enough to produce the types of innovative treatments demanded by global markets. In order to make the most of these future growth opportunities, the industry must fundamentally change the way it operates.